Peter Rahmer - Chief Corporate Development Officer at Relay Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Corporate Development Officer
Issuer Symbol
RLAY on Nasdaq
All Insider Reports
All Insider Reports

Peter Rahmer - trading volume in the past year for Relay Therapeutics, Inc.

Holdings reported by Peter Rahmer for Relay Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 276,610 $2,337,354 $8.45 28 Jan 2026 Direct
Stock Option (Right to Buy) 475,000 13 Jan 2026 Direct Common Stock

Transactions reported by Peter Rahmer for Relay Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.